Out-of-specification results were found for atomoxetine content, below the lower specification limit, and for one batch non‑compliant capsule mass uniformity; the risk assessment indicated mainly potentially reduced drug efficacy. Potential effects: lack of or reduced treatment effectiveness.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from the listed batches; check the batch number on the packaging and, if you have such medicine, return it to the pharmacy and consult a doctor if in doubt.
The specified medicinal product batches were withdrawn from the market nationwide, their placing on the market was prohibited, and the decision was given immediate enforceability; previously, distribu...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related